Re-Vana Therapeutics raises $11.9m to boost eye disease treatment
Re-Vana Therapeutics is developing technology that can provide sustained drug delivery for up to six months for people with eye diseases.
Source: siliconrepublic.com
Page 2 - Exsight Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Exsight Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Exsight Ventures Today - Breaking & Trending Today
RE-VANA THERAPEUTICS RAISES $11.9 MILLION IN SERIES A FINANCING
/PRNewswire/ -- Re-Vana Therapeutics Ltd, a privately-held specialty drug delivery company developing sustained-release therapeutics for the treatment of...
Source: prnewswire.co.uk
RE-VANA THERAPEUTICS RAISES $11.9 MILLION IN SERIES A FINANCING
/PRNewswire/ -- Re-Vana Therapeutics Ltd, a privately-held specialty drug delivery company developing sustained-release therapeutics for the treatment of...
Source: prnewswire.com
Re-Vana Therapeutics Raises USD11.9M in Series A Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Ophthalmic Drugs Market Size Worth $65.6 Billion by 2030: Grand View Research, Inc.
/PRNewswire/ -- The global ophthalmic drugs market size is expected to reach USD 65.6 billion by 2030, garnering a CAGR of 7.7% from 2022 to 2030, according to...
Source: prnewswire.com